HIV-1 and Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 18, Issue 1 SUPPL., 2012, Pages

  Durand, Christine ^a   Ambinder, Richard ^a   Blankson, Joel ^a   Forman, Stephen ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; CHEMOKINE RECEPTOR CCR5; CYCLOSPORIN; INDINAVIR; MIDAZOLAM; PHENYTOIN; RAPAMYCIN; RITONAVIR; SULFADOXINE PLUS TRIMETHOPRIM; TACROLIMUS; VORICONAZOLE; ZIDOVUDINE; ZINC FINGER PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CYTOTOXIC T LYMPHOCYTE; DISEASE CARRIER; DISEASE COURSE; DRUG WITHDRAWAL; GENE THERAPY; GENOTYPE; HEALTH CARE COST; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES ZOSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HYPERBILIRUBINEMIA; INFECTION CONTROL; INFECTION RESISTANCE; LYMPHOMA; MEMORY T LYMPHOCYTE; NAUSEA; NONHODGKIN LYMPHOMA; SINGLE NUCLEOTIDE POLYMORPHISM; VIREMIA; VIRUS ENTRY; VIRUS LOAD; VOMITING;

ACQUIRED IMMUNODEFICIENCY SYNDROME; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIV-1; HUMANS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84855413314     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.10.027     Document Type: Article

References (27)

1. Haggerty C.M., Pitt E., Siliciano R.F. The latent reservoir for HIV-1 in resting CD4+ T cells and other viral reservoirs during chronic infection: insights from treatment and treatment-interruption trials. Curr Opin HIV AIDS 2006, 1:62-68.
2. Liu R., Paxton W.A., Choe S., et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996, 86:367-377.
3. Samson M., Libert F., Doranz B.J., et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996, 382:722-725.
4. Hutter G., Nowak D., Mossner M., et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med 2009, 360:692-698.
5. Allers K., Hutter G., Hofmann J., et al. Evidence for the cure of HIV infection by CCR5{Delta}32/{Delta}32 stem cell transplantation. Blood 2011, 117:2791-2799.
6. Okulicz J.F., Lambotte O. Epidemiology and clinical characteristics of elite controllers. Curr Opin HIV AIDS 2011, 6:163.
7. Blankson J.N., Bailey J.R., Thayil S., et al. Isolation and characterization of replication-competent HIV-1 from a subset of elite suppressors. J Virol 2007, 81:2508-2518.
8. Miura T., Brockman M.A., Brumme C.J., et al. Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes. J Virol 2008, 82:8422-8430.
9. Pereyra F. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010, 330:1551-1557. for the International HIV Controllers Study.
10. Fellay J., Shianna K.V., Ge D., et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007, 317:944-947.
11. Martin M.P., et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 2007, 39:733-740.
12. O'Connell K.A., Bailey J.R., Blankson J.N. Elucidating the elite: mechanisms of control in HIV-1 infection. Trends Pharmacol Sci 2009, 30:631-637.
13. Scarlatti G., Tresoldi E., Bjorndal A., et al. Invivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat Med 1997, 3:1259-1265.
14. Hendrix C.W., Collier A.C., Lederman M.M., et al. Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection. J Acquir Immune Defic Syndr 2004, 37:1253.
15. Dean M., Carrington M., Winkler C., et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996, 273:1856-1862.
16. Huang Y., Paxton W.A., Wolinsky W.M., et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996, 2:1240-1243.
17. Rossi J.J., June C.H., Kohn D.B. Genetic therapies against HIV. Nat Biotechnol 2007, 25:1444-1454.
18. DiGiusto D.L., Krishnan A., Li L., et al. RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma. Sci Transl Med 2010, 2:36ra43.
19. Perez E.E., Wang J., Miller J.C., et al. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat. Biotechnol 2008, 26:808-816.
20. Krishnan A., Palmer J.M., Zaia J.A., Tsai N.C., Alvarnas J., Forman S.J. HIV status does not affect the outcome of autologous stem cell transplantation (ASCT) for non-Hodgkin lymphoma (NHL). Biol Blood Marrow Transplant 2010, 16:1302-1308.
21. Diez-Martin J.L., Balsalobre P., Re A., et al. Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation. Blood 2009, 113:6011-6014.
22. Ambinder R.F. The same but different: autologous hematopoietic stem cell transplantation for patients with lymphoma and HIV infection. Bone Marrow Transplant 2009, 44:1-5.
23. Krishnan A., Molina A., Zaia J., et al. Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas. Blood 2005, 105:874-878.
24. Krishnan A., Forman S.J. Hematopoietic stem cell transplantation for AIDS-related malignancies. Curr Opin Oncol 2010, 22:456-460.
25. Persad G.C., Little R.F., Grady C. Including persons with HIV infection in cancer clinical trials. J Clin Oncol 2008, 26:1027-1032.
26. Rudek M.A., Flexner C., Ambinder R.F. Use of antineoplastic agents in patients with cancer who have HIV/AIDS. Lancet Oncol 2011, 12:905-912.
27. Brunstein C.G., Fuchs E.J., Carter S.L., et al. Alternative donor transplantation: results of parallel phase II trials using HLA-mismatched related bone marrow or unrelated umbilical cord blood grafts. Blood 2011.